Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom
Tue, February 9, 2021, 6:00 AM·4 min read
TLRY
+16.99%
Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK
New UK agreement gives doctors and patients access to a sustainable supply of Tilray’s pharmaceutical-grade medical cannabis products
Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has established an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products into the United Kingdom (UK). This agreement allows Tilray to provide
